Atlas Trials

Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation

Clinical trial NCT04232722 · UNKNOWN

Trial details

NCT number
NCT04232722
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HCC
Start date
2020-01-01
Primary completion
2021-12-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.